Abstract
Biomolecules containing the RGD peptide sequence are known to bind integrins with high affinity. Studies of hexa-and hepta-peptides labeled with a near-infrared fluorescent probe (cypate) showed that rearranging the glycine in a linear RGD peptide sequence to form the GRD analogue favored the uptake of the GRD compound by αvβ3 integrin receptor (ABIR)-positive A549 tumor cells and tissue. The internalization of the GRD compound in A549 cells and tumor uptake in mice were inhibited by ABIR-avid peptides, suggesting its recognition by this receptor. Further studies with functional blocking antibodies and β3 knockout cells revealed that β3 integrin mediates the internalization of the cypate-GRD peptide. Molecular modeling studies supported preferential interaction of the probe with the β3 subunit of integrins relative to the αv subunit. The results demonstrate that the cypate-GRD peptide targets β3 integrin, thereby providing a strategy to monitor drug delivery and efficacy, and physiopathologic processes mediated by this protein.
Original language | English (US) |
---|---|
Pages (from-to) | 539-549 |
Number of pages | 11 |
Journal | Molecular Pharmaceutics |
Volume | 3 |
Issue number | 5 |
DOIs | |
State | Published - Sep 2006 |
Externally published | Yes |
Keywords
- Cancer
- Imaging
- Integrin
- Molecular probe
- Near-infrared
ASJC Scopus subject areas
- Molecular Medicine
- Pharmaceutical Science
- Drug Discovery